Dr Arianna Dal Buono, IRCCS Humanitas Research Hospital, Jamaica
Dr. Arianna Dal Buono is a dynamic clinician-scientist specializing in gastroenterology and inflammatory bowel diseases (IBD). She serves as an Assistant Specialist in Gastroenterology and Digestive Endoscopy at the Humanitas Research Hospital in Milan, where she contributes to the IBD Unit led by Prof. Alessandro Armuzzi. With dual medical licensure in Italy and Germany, Dr. Dal Buono has a strong academic foundation, currently pursuing a PhD in Applied Clinical Research at Humanitas University. She combines clinical excellence with scientific inquiry, participating in pioneering research on ulcerative colitis, bowel ultrasound, and drug development in IBD. Her publications in top-tier journals and contributions to multicenter studies demonstrate her commitment to advancing gastrointestinal science. Through her academic rigor, international exposure, and translational research focus, Dr. Dal Buono exemplifies the spirit of the Best Researcher Award.
Publication Profile
Orcid
Education
Dr. Dal Buono earned her Laurea Magistrale in Medicine and Surgery from La Sapienza University of Rome in 2016 with top honors (110/110 e lode). Her international perspective was broadened through multiple Erasmus exchanges at Charité University of Berlin. In 2017, she obtained German medical licensure. She pursued a postgraduate specialization in Gastroenterology at Humanitas Research Hospital (2018–2022), graduating with distinction (70/70 cum laude). She enhanced her technical capabilities with the International Bowel Ultrasound Group (IBUS) Curriculum in 2023–2024. Currently, she is pursuing a PhD in Applied Clinical Research at Humanitas University. Her comprehensive educational journey across Europe underpins her clinical and research expertise in gastroenterology and inflammatory bowel disease.
Experience
Since March 2022, Dr. Dal Buono has been an Assistant Specialist in Gastroenterology and Digestive Endoscopy at the Humanitas Research Hospital, contributing to the Inflammatory Bowel Disease (IBD) Unit. Her work bridges patient care and cutting-edge research under the mentorship of Prof. Armuzzi. She has also been involved in cross-border clinical training, particularly at Charité University of Berlin through multiple Erasmus and traineeship programs. Her involvement in multicenter clinical studies, systematic reviews, and guideline development has significantly impacted therapeutic strategies for ulcerative colitis, Barrett’s esophagus, and gastroenteropancreatic neuroendocrine tumors. She also contributes to teaching and mentoring younger colleagues and students in endoscopic techniques and IBD management.
Awards and Honors
Dr. Arianna Dal Buono has been recognized with several prestigious academic distinctions throughout her career. She received the Erasmus Student Mobility for Traineeships award (2017) and participated in multiple Erasmus exchange programs at Charité University of Berlin (2015, 2016), reflecting her international academic engagement. In 2016, she was awarded a Scholarship for her final thesis at La Sapienza University. Her high school and university honors, including a perfect score of 110/110 with distinction in medical school and 97/100 in high school, underline her academic excellence from an early age. Her achievements also include invitations to collaborate on international multicenter studies and contributions to high-impact journal publications—an indication of her growing influence in gastrointestinal research.
Research Focus
Dr. Dal Buono’s research centers on inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease, with a particular interest in imaging, biomarkers, histologic healing, and precision treatment strategies such as “treat-to-target” and “treat-to-clear.” Her studies on histological healing and disease monitoring through bowel ultrasound are redefining IBD management approaches. She is also exploring the role of TL1A as a therapeutic target, non-invasive disease activity assessments, and outcomes in difficult-to-treat IBD cases. Additionally, her work includes contributions to the development of evaluation scales such as the GRACE Scale and understanding drug safety in elderly populations. Dr. Dal Buono’s work is highly translational, linking clinical findings to therapeutic advances. Her collaborative publications with global leaders in the field further establish her as a rising expert in gastroenterological research.
Publication Top Notes